Aquestive Therapeutics News

Aquestive Therapeutics Price Target Announced at $8.00/Share by Leerink Partners

Aquestive Therapeutics Price Target Announced at $8.00/Share by Leerink Partners

Dow Jones03:09

Aquestive Therapeutics Initiated at Outperform by Leerink Partners

Aquestive Therapeutics Initiated at Outperform by Leerink Partners

Dow Jones03:09

Aquestive Therapeutics (AQST.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $8.00.

Aquestive Therapeutics (AQST.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $8.00.

Zhitong Finance03:02

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

Aquestive Therapeutics (AQST) has an average rating of buy and price targets ranging from $5.50 to $13, according to analysts polled by Capital IQ.

MT NewswiresMay 10 19:11

Buy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial Prospects

TipRanksMay 10 18:39

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 10 04:51

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Last week, you might have seen that Aquestive Therapeutics, Inc. (NASDAQ:AQST) released its first-quarter result to the market. The early response was not positive, with shares down 5.9% to US$3.09 in

Simply Wall StMay 9 20:03

Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ), MannKind (MNKD) and Aquestive Therapeutics (AQST)

TipRanksMay 9 18:50

Buy Rating Affirmed for Aquestive Therapeutics Amid Solid Finances and Promising Anaphylm Prospects

TipRanksMay 9 18:39

Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 9 15:05

Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript

Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 9 00:32

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)

TipRanksMay 9 00:20

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)

TipRanksMay 8 21:01

Aquestive Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

Aquestive Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

BenzingaMay 8 20:49

Aquestive Therapeutics Presents to Investors and Analysts

TipRanksMay 8 18:13

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Yahoo FinanceMay 8 07:00

Aquestive Therapeutics Continues To Expect FY24 Total Revenue Of $48M-$51M, Est $50.214M

Cash and cash equivalents were $95.2 million as of March 31, 2024. Extended cash runway into 2026 with completion of $77.5 million underwritten public offering with high quality institutional healthca

BenzingaMay 8 06:02

Aquestive Therapeutics Q1 2024 GAAP EPS $(0.17) Misses $(0.07) Estimate, Sales $12.053M Miss $12.262M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.07) by 142.86 percent. This is a 254.55 percent decrease over ear

BenzingaMay 8 05:48

Aquestive Therapeutics Shares Investor Presentation Update

TipRanksMay 8 04:33

Aquestive Therapeutics | 10-Q: Quarterly report

Futu NewsMay 8 04:31 · Announcements